FDA grants emergency use for Regeneron's antibody cocktail in COVID-19 treatment
The U.S. Food and Drug Administration issued emergency use authorization for Regeneron Pharmaceuticals' antibody cocktail, previously administered to President Donald Trump, to treat high-risk COVID-19 patients.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthFDA grants emergency use for Regeneron's antibody cocktail in COVID-19 treatment
Sign in or subscribeBrowse free archive reportsThe U.S. Food and Drug Administration issued emergency use authorization for Regeneron Pharmaceuticals' antibody cocktail, previously administered to President Donald Trump, to treat high-risk COVID-19 patients.